Tenaya Therapeutics
TNYA | NASDAQ
$0.39
-$0.13 (-25.14%)
At close: Oct 14, 2026, 4:00 PM ET
-25.14%
(1D)Rating
Key Statistics
Market Data
Market Cap $84.74M
1D Range
0.36 0.51
52W Range
0.36 2.04
Valuation (TTM)
PE -0.74
PB 1.22
EV/EBITDA -0.11
Valuation (NTM)
Forward PE 10.73
Forward PEG 0.05
Price Target $2.33
Cash Flow
FCF Yield -84.8%
SBC Adj. FCF Yield -98.7%
SBC Impact -16.4%
Margins
Gross Margin 263.7%
Operating Margin -7929.9%
FCF Margin -5380.8%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 51.0% |
35.4%
FCF 3Y | 5Y 16.3% |
13.7%
Returns
ROA -110.2%
ROE -108.0%
ROIC -136.8%
Financial Health
Net Cash
$78.09M
Current Ratio 4.52
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gen...
Sector Healthcare
Industry Biotechnology
Employees 70
IPO Date Jul 30, 2021
Website www.tenayatherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$2.00
Upside
+412.82%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TNYA